Focus: Valuing and executing acquisitions of revenue-generating pharmaceutical assetsDomain / Therapy Area: Pharmaceuticals, Corporate Development and M&AA mid-sized European specialty pharmaceutical company is rebuilding its corporate development function to drive growth through acquisition. The near-term priority is acquiring profitable, revenue-generating marketed assets across Europe within the next 12 to 18 months. The M&A Specialist will own the formal transaction process, working closely with business development, cross-functional teams and external advisers. This is a hands-on role in a team that is still taking shape, with high visibility to executive leadership and the board.What You Will DoScreen opportunities from business development and investment bank teasers against agreed strategic and financial criteria.Build risk-adjusted NPV, DCF, comparable and precedent transaction models to value pharmaceutical assets and companies.Own the formal transaction process from bid preparation and negotiation analysis through signing and closing.Coordinate cross-functional due diligence workstreams, data-room reviews and red-flag reporting on decision-critical risks.Prepare clear investment cases and recommendations for executive and board-level decision bodies.Manage investment banks, legal counsel, tax advisers,



consultants and counterparties throughout each transaction.Support integration planning and track synergies, value-creation milestones and post-close performance.Maintain deal tracking, transaction timetables and sector intelligence on valuations and competitive activity.What We’re Looking ForRecent, hands-on M&A deal experience within the last three years.Background in pharma or biotech corporate development, investment banking, transaction advisory, consulting, private equity or venture capital.Healthcare or pharmaceutical transaction experience preferred, with openness to strong candidates from the advisory side.Strong financial modelling, valuation, accounting and presentation skills, with close attention to assumptions and data quality.Working knowledge of clinical development, regulatory approval, IP, exclusivity, pricing, reimbursement and market access.Good understanding of European pharmaceutical markets, players and regulations.Degree in finance, economics, business, life sciences or a related field; MBA, CFA or ACA advantageous.Team player with fluent business English, comfortable with ambiguity and confident challenging senior stakeholders.#J-18808-Ljbffr

📌 Mergers And Acquisitions Specialist (Madrid)
🏢 Valtera Group
📍 Madrid